Correlation Between Takeda Pharmaceutical and Grown Rogue

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Grown Rogue at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Grown Rogue into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Grown Rogue International, you can compare the effects of market volatilities on Takeda Pharmaceutical and Grown Rogue and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Grown Rogue. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Grown Rogue.

Diversification Opportunities for Takeda Pharmaceutical and Grown Rogue

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Takeda and Grown is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Grown Rogue International in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grown Rogue International and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Grown Rogue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grown Rogue International has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Grown Rogue go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Grown Rogue

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.29 times more return on investment than Grown Rogue. However, Takeda Pharmaceutical Co is 3.43 times less risky than Grown Rogue. It trades about -0.03 of its potential returns per unit of risk. Grown Rogue International is currently generating about -0.07 per unit of risk. If you would invest  1,360  in Takeda Pharmaceutical Co on August 28, 2024 and sell it today you would lose (11.00) from holding Takeda Pharmaceutical Co or give up 0.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Takeda Pharmaceutical Co  vs.  Grown Rogue International

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Grown Rogue International 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Grown Rogue International are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Grown Rogue may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Takeda Pharmaceutical and Grown Rogue Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and Grown Rogue

The main advantage of trading using opposite Takeda Pharmaceutical and Grown Rogue positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Grown Rogue can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grown Rogue will offset losses from the drop in Grown Rogue's long position.
The idea behind Takeda Pharmaceutical Co and Grown Rogue International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments